{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,24]],"date-time":"2025-07-24T12:22:22Z","timestamp":1753359742653,"version":"3.41.0"},"reference-count":51,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2022,11]]},"abstract":"<jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>To assess the correlation between profile and severity deterioration in the neuropsychological assessment and the most affected regions in amyloid PET semiquantification. The influence of vascular risk and other potential confounding factors was also evaluated.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A retrospective, observational, and multicenter study including all patients referred for amyloid PET in daily practice was conducted. Patients underwent neuropsychological assessment, and cognitive decline severity and domain(s) affected were recorded. The patients were grouped according to cognitive impairment (CI) profile and severity: (A) no CI, single-domain amnestic CI, multiple-domain amnestic CI, and nonamnestic CI; and (B) mild CI, moderate and severe dementia. An adapted Framingham Stroke Risk Profile was calculated for each individual. Depression and parkinsonism were also recorded. Standardized quantitative analysis software was used to obtain standardized uptake value ratio (SUVR) values from PET\/CT images. The corresponding associations were assessed with the most appropriate statistical tests.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>One hundred twenty-nine patients were included (62 men, 67 women; 64.67 \u00b1 7.47 years old). Significant differences in global and regional amyloid load were exclusively found in women between non-CI and moderate dementia (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.006, for total-cerebellum SUVR). Posterior and anterior cingulates and prefrontal cortex best represented CI severity (<jats:italic toggle=\"yes\">P<\/jats:italic> = 0.003, 0.006, and 0.006, respectively). No relationship between the CI profile and the regional amyloid load was shown. A significantly high positive correlation was found between age and vascular risk and between these variables and amyloid load in nearly all regions, especially in women with moderate dementia.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Semiquantitative analysis of amyloid PET by SUVR values revealed a significant correlation between amyloid burden and CI severity, although only in women.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/rlu.0000000000004370","type":"journal-article","created":{"date-parts":[[2022,10,10]],"date-time":"2022-10-10T18:25:48Z","timestamp":1665426348000},"page":"923-930","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Correlation of Global and Regional Amyloid Burden by 18F-Florbetaben PET\/CT With Cognitive Impairment Profile and Severity"],"prefix":"10.1097","volume":"47","author":[{"given":"Francisco Jos\u00e9","family":"Pena Pardo","sequence":"first","affiliation":[{"name":"Nuclear Medicine Department, University General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana Mar\u00eda","family":"Garc\u00eda Vicente","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Department, University General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariano","family":"Amo-Salas","sequence":"additional","affiliation":[{"name":"Mathematics Department, Castilla La Mancha University, Ciudad Real"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz","family":"Mond\u00e9jar Mar\u00edn","sequence":"additional","affiliation":[{"name":"Neurology Department, Complejo Hospitalario de Toledo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Santiago","family":"Navarro Mu\u00f1oz","sequence":"additional","affiliation":[{"name":"Neurology Department, La Mancha Centro Hospital, Alc\u00e1zar de San Juan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piedad","family":"Garc\u00eda Hortelano","sequence":"additional","affiliation":[{"name":"Neuropsychology Department, University General Hospital, Ciudad Real, Spain."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignacio","family":"Rueda Medina","sequence":"additional","affiliation":[{"name":"Neurology Department, La Mancha Centro Hospital, Alc\u00e1zar de San Juan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eloy","family":"Garc\u00eda P\u00e9rez","sequence":"additional","affiliation":[{"name":"Neuropsychology Department, University General Hospital, Ciudad Real, Spain."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda","family":"Padilla-Bermejo","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Department, University General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V\u00edctor Manuel","family":"Poblete Garc\u00eda","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Department, University General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Marsal Alonso","sequence":"additional","affiliation":[{"name":"Neurology Department, Complejo Hospitalario de Toledo"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c1ngel","family":"Soriano Castrej\u00f3n","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Department, University General Hospital"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2022,8,12]]},"reference":[{"key":"bib1-20250621","first-page":"e-1","article-title":"Appropriate use criteria for amyloid PET: a report of the Amyloid Imaging Task Force, the Society of Nuclear Medicine and Molecular Imaging, and the Alzheimer's Association","volume":"9","year":"2013","journal-title":"Alzheimers Dement"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1474-4422(09)70299-6","article-title":"Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade","volume":"9","year":"2010","journal-title":"Lancet Neurol"},{"key":"bib3-20250621","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.jalz.2011.03.003","article-title":"Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","year":"2011","journal-title":"Alzheimers Dement"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jalz.2011.03.008","article-title":"The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","year":"2011","journal-title":"Alzheimers Dement"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease","volume":"7","year":"2011","journal-title":"Alzheimers Dement"},{"issue":"2 dementia","key":"bib7-20250621","first-page":"419","article-title":"Alzheimer disease","volume":"22","year":"2016","journal-title":"Continuum (Minneap Minn)"},{"key":"bib8-20250621","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.cger.2018.06.006","article-title":"Alzheimer disease","volume":"34","year":"2018","journal-title":"Clin Geriatr Med"},{"key":"bib9-20250621","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1177\/1533317518791401","article-title":"Mild cognitive impairment in clinical practice: a review article","volume":"33","year":"2018","journal-title":"Am J Alzheimers Dis Other Demen"},{"key":"bib10-20250621","doi-asserted-by":"crossref","first-page":"390","DOI":"10.2967\/jnumed.107.045385","article-title":"Multicenter standardized 18F-FDG PET diagnosis of mild cognitive impairment, Alzheimer's disease, and other dementias","volume":"49","year":"2008","journal-title":"J Nucl Med"},{"key":"bib11-20250621","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ejrad.2017.07.014","article-title":"The diagnostic value of FDG and amyloid PET in Alzheimer's disease\u2014a systematic review","volume":"94","year":"2017","journal-title":"Eur J Radiol"},{"key":"bib12-20250621","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1002\/ana.24040","article-title":"Predicting Alzheimer disease with \u03b2-amyloid imaging: results from the Australian imaging, biomarkers, and lifestyle study of ageing","volume":"74","year":"2013","journal-title":"Ann Neurol"},{"key":"bib13-20250621","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1148\/radiol.2020200028","article-title":"Molecular imaging approaches in dementia","volume":"298","year":"2021","journal-title":"Radiology"},{"key":"bib14-20250621","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1212\/WNL.0b013e3182840bbe","article-title":"Brain \u03b2-amyloid load approaches a plateau","volume":"80","year":"2013","journal-title":"Neurology"},{"key":"bib15-20250621","first-page":"303","article-title":"Recommendations for the use of PET imaging biomarkers in the diagnosis of neurodegenerative conditions associated with dementia: SEMNIM and SEN consensus","volume":"34","year":"2015","journal-title":"Rev Esp Med Nucl Imagen Mol"},{"key":"bib16-20250621","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.jalz.2016.06.2365","article-title":"Detecting cognitive changes in preclinical Alzheimer's disease: a review of its feasibility","volume":"13","year":"2017","journal-title":"Alzheimers Dement"},{"key":"bib17-20250621","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1007\/s11065-017-9366-0","article-title":"Correction to: detectable neuropsychological differences in early preclinical Alzheimer's disease: a meta-analysis","volume":"27","year":"2017","journal-title":"Neuropsychol Rev"},{"key":"bib18-20250621","doi-asserted-by":"crossref","first-page":"445","DOI":"10.31887\/DCNS.2013.15.4\/hjahn","article-title":"Memory loss in Alzheimer's disease","volume":"15","year":"2013","journal-title":"Dialogues Clin Neurosci"},{"key":"bib19-20250621","doi-asserted-by":"crossref","first-page":"935","DOI":"10.3349\/ymj.2019.60.10.935","article-title":"Distinct neural correlates of executive function by amyloid positivity and associations with clinical progression in mild cognitive impairment","volume":"60","year":"2019","journal-title":"Yonsei Med J"},{"key":"bib20-20250621","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/ene.12761","article-title":"Regional \u03b2-amyloid burden does not correlate with cognitive or language deficits in Alzheimer's disease presenting as aphasia","volume":"23","year":"2016","journal-title":"Eur J Neurol"},{"key":"bib21-20250621","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.nicl.2017.04.025","article-title":"Optimized classification of 18F-florbetaben PET scans as positive and negative using an SUVR quantitative approach and comparison to visual assessment","volume":"15","year":"2017","journal-title":"Neuroimage Clin"},{"key":"bib22-20250621","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1212\/01.wnl.0000271090.28148.24","article-title":"Mixed brain pathologies account for most dementia cases in community-dwelling older persons","volume":"69","year":"2007","journal-title":"Neurology"},{"key":"bib23-20250621","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/s41440-019-0357-9","article-title":"Roles of vascular risk factors in the pathogenesis of dementia","volume":"43","year":"2020","journal-title":"Hypertens Res"},{"key":"bib24-20250621","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1016\/j.jacc.2020.03.053","article-title":"Associations between cardiovascular risk, structural brain changes, and cognitive decline","volume":"75","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"bib25-20250621","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.jalz.2019.06.001","article-title":"Preventing dementia by preventing stroke: the Berlin manifesto","volume":"15","year":"2019","journal-title":"Alzheimers Dement"},{"key":"bib26-20250621","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/abbs\/gmz115","article-title":"Interrelationship between Alzheimer's disease and cardiac dysfunction: the brain-heart continuum?","volume":"52","year":"2020","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"bib27-20250621","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1080\/00325481.2019.1657776","article-title":"Alzheimer's dementia: pathogenesis and impact of cardiovascular risk factors on cognitive decline","volume":"131","year":"2019","journal-title":"Postgrad Med"},{"key":"bib28-20250621","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/s41398-019-0456-z","article-title":"Cortical \u03b2-amyloid burden, neuropsychiatric symptoms, and cognitive status: the Mayo Clinic study of aging","volume":"9","year":"2019","journal-title":"Transl Psychiatry"},{"key":"bib29-20250621","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1177\/1073191117691608","article-title":"Novel cognitive paradigms for the detection of memory impairment in preclinical Alzheimer's disease","volume":"25","year":"2018","journal-title":"Assessment"},{"key":"bib30-20250621","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.jalz.2014.09.001","article-title":"Independent comparison of CogState computerized testing and a standard cognitive battery with neuroimaging","volume":"10","year":"2014","journal-title":"Alzheimers Dement"},{"key":"bib31-20250621","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/jch.13175","article-title":"Framingham Stroke Risk Profile is related to cerebral small vessel disease progression and lower cognitive performance in patients with hypertension","volume":"20","year":"2018","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"bib32-20250621","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3233\/JAD-180965","article-title":"Vascular burden score impacts cognition independent of amyloid PET and MRI measures of Alzheimer's disease and vascular brain injury","volume":"68","year":"2019","journal-title":"J Alzheimers Dis"},{"key":"bib33-20250621","first-page":"1579","article-title":"An automated method for rotational correction and centering of three-dimensional functional brain images","volume":"33","year":"1992","journal-title":"J Nucl Med"},{"key":"bib34-20250621","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1161\/01.STR.25.1.40","article-title":"Stroke risk profile: adjustment for antihypertensive medication. The Framingham Study","volume":"25","year":"1994","journal-title":"Stroke"},{"key":"bib35-20250621","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1007\/s00259-011-1821-1","article-title":"Individualized quantification of brain \u03b2-amyloid burden: results of a proof of mechanism phase 0 florbetaben PET trial in patients with Alzheimer's disease and healthy controls","volume":"38","year":"2011","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"bib36-20250621","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/ana.22248","article-title":"Longitudinal assessment of A\u03b2 and cognition in aging and Alzheimer disease","volume":"69","year":"2011","journal-title":"Ann Neurol"},{"key":"bib37-20250621","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/alzrt158","article-title":"(18)F-florbetaben A\u03b2 imaging in mild cognitive impairment","volume":"5","year":"2013","journal-title":"Alzheimers Res Ther"},{"key":"bib38-20250621","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1212\/WNL.0000000000001738","article-title":"Memory, executive, and multidomain subtle cognitive impairment: clinical and biomarker findings","volume":"85","year":"2015","journal-title":"Neurology"},{"key":"bib39-20250621","first-page":"1512","article-title":"Associations between Alzheimer disease biomarkers, neurodegeneration, and cognition in cognitively normal older people","volume":"70","year":"2013","journal-title":"JAMA Neurol"},{"key":"bib40-20250621","doi-asserted-by":"crossref","first-page":"7709","DOI":"10.1523\/JNEUROSCI.2177-05.2005","article-title":"Molecular, structural, and functional characterization of Alzheimer's disease: evidence for a relationship between default activity, amyloid, and memory","volume":"25","year":"2005","journal-title":"J Neurosci"},{"key":"bib41-20250621","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/ana.20009","article-title":"Imaging brain amyloid in Alzheimer's disease with Pittsburgh compound-B","volume":"55","year":"2004","journal-title":"Ann Neurol"},{"key":"bib42-20250621","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s13195-020-00742-y","article-title":"Association of A\u03b2 deposition and regional synaptic density in early Alzheimer's disease: a PET imaging study with [11C]UCB-J","volume":"13","year":"2021","journal-title":"Alzheimers Res Ther"},{"key":"bib43-20250621","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s12149-020-01453-y","article-title":"Relationships between amyloid levels, glucose metabolism, morphologic changes in the brain and clinical status of patients with Alzheimer's disease","volume":"34","year":"2020","journal-title":"Ann Nucl Med"},{"key":"bib44-20250621","first-page":"3105","article-title":"Cerebrospinal fluid biomarkers for Alzheimer's disease: the role of apolipoprotein E genotype, age, and sex","volume":"11","year":"2015","journal-title":"Neuropsychiatr Dis Treat"},{"key":"bib45-20250621","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.1093\/brain\/awaa327","article-title":"The accumulation rate of tau aggregates is higher in females and younger amyloid-positive subjects","volume":"143","year":"2020","journal-title":"Brain"},{"key":"bib46-20250621","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.neurobiolaging.2021.04.003","article-title":"Multimodal neuroimaging of sex differences in cognitively impaired patients on the Alzheimer's continuum: greater tau-PET retention in females","volume":"105","year":"2021","journal-title":"Neurobiol Aging"},{"key":"bib47-20250621","doi-asserted-by":"crossref","first-page":"633576","DOI":"10.3389\/fnins.2021.633576","article-title":"The associations of cerebrospinal fluid ApoE and biomarkers of Alzheimer's disease: exploring interactions with sex","volume":"15","year":"2021","journal-title":"Front Neurosci"},{"key":"bib48-20250621","doi-asserted-by":"crossref","first-page":"105248","DOI":"10.1016\/j.psyneuen.2021.105248","article-title":"Sex influences the effects of ApoE genotype and Alzheimer's diagnosis on neuropathology and memory","volume":"129","year":"2021","journal-title":"Psychoneuroendocrinology"},{"key":"bib49-20250621","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.jalz.2018.04.010","article-title":"Sex, amyloid, and ApoE \u03b54 and risk of cognitive decline in preclinical Alzheimer's disease: findings from three well-characterized cohorts","volume":"14","year":"2018","journal-title":"Alzheimers Dement"},{"key":"bib50-20250621","doi-asserted-by":"crossref","first-page":"87","DOI":"10.5114\/fn.2019.85929","article-title":"Risk factors for Alzheimer's disease","volume":"57","year":"2019","journal-title":"Folia Neuropathol"},{"key":"bib51-20250621","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/s41593-018-0234-x","article-title":"The role of brain vasculature in neurodegenerative disorders","volume":"21","year":"2018","journal-title":"Nat Neurosci"},{"key":"bib52-20250621","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1001\/jamaneurol.2018.1123","article-title":"Interactive associations of vascular risk and \u03b2-amyloid burden with cognitive decline in clinically normal elderly individuals: findings from the Harvard Aging Brain Study","volume":"75","year":"2018","journal-title":"JAMA Neurol"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004370","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T20:03:25Z","timestamp":1750536205000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000004370"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,12]]},"references-count":51,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000004370","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"type":"electronic","value":"1536-0229"},{"type":"print","value":"0363-9762"}],"subject":[],"published":{"date-parts":[[2022,8,12]]}}}